Baseline ctDNA Gene Alterations as a Biomarker of Survival After Panitumumab and Chemotherapy for Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer
Nat. Med. 2024 Feb 12;[EPub Ahead of Print], K Shitara, K Muro, J Watanabe, K Yamazaki, H Ohori, M Shiozawa, A Takashima, M Yokota, A Makiyama, N Akazawa, H Ojima, Y Yuasa, K Miwa, H Yasui, E Oki, T Sato, T Naitoh, Y Komatsu, T Kato, I Mori, K Yamanaka, M Hihara, J Soeda, T Misumi, K Yamamoto, R Yamashita, K Akagi, A Ochiai, H Uetake, K Tsuchihara, T YoshinoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.